KDM1 is a novel therapeutic target for the treatment of gliomas
Open Access
- 17 November 2012
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 4 (1) , 18-28
Abstract
Glioma development is a multistep process, involving alterations in genetic and epigenetic mechanisms. Understanding the mechanisms and enzymes that promote epigenetic changes in gliomas are urgently needed to identify novel therapeutic targets. We examined the role of histone demethylase KDM1 in glioma progression. KDM1 was overexpressed in gliomas and its expression positively correlated with histological malignancy. Knockdown of KDM1 expression or its pharmacological inhibition using pargyline or NCL-1 significantly reduced the proliferation of glioma cells. Inhibition of KDM1 promoted up regulation of the p53 target genes p21 and PUMA. Patient-derived primary GBM cells expressed high levels of KDM1 and pharmacological inhibition of KDM1 decreased their proliferation. Further, KDM1 inhibition reduced the expression of stemness markers CD133 and nestin in GBM cells. Mouse xenograft assays revealed that inhibition of KDM1 significantly reduced glioma xenograft tumor growth. Inhibition of KDM1 increased levels of H3K4-me2 and H3K9-Ac histone modifications, reduced H3K9-me2 modification and promoted expression of p53 target genes (p21 and PUMA), leading to apoptosis of glioma xenograft tumors. Our results suggest that KDM1 is overexpressed in gliomas and could be a potential therapeutic target for the treatment of gliomas.Keywords
This publication has 33 references indexed in Scilit:
- Emerging insights into the molecular and cellular basis of glioblastomaGenes & Development, 2012
- Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemiaNature Medicine, 2012
- Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitorsNeuro-Oncology, 2011
- LSD1 regulates the balance between self-renewal and differentiation in human embryonic stem cellsNature Cell Biology, 2011
- Mechanisms involved in the regulation of histone lysine demethylasesCurrent Opinion in Cell Biology, 2008
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Opposing LSD1 complexes function in developmental gene activation and repression programmesNature, 2007
- Chromatin Modifications and Their FunctionCell, 2007
- Histone Methylation-Dependent Mechanisms Impose Ligand Dependency for Gene Activation by Nuclear ReceptorsCell, 2007
- LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcriptionNature, 2005